Avid Bioservices (CDMO) Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand Dec 30, 2024 09:02AM
Stephens Reiterates Equal Weight Rating on Avid Bioservices (CDMO) Dec 11, 2024 06:46AM
Avid Bioservices (CDMO) Misses Q2 EPS by 17c Dec 10, 2024 04:08PM
RBC Capital Downgrades Avid Bioservices (CDMO) to Sector Perform Nov 7, 2024 04:19AM
KeyBanc Reiterates Overweight Rating on Avid Bioservices (CDMO) Sep 30, 2024 08:44AM


Sep 10, 2024 06:19AM Avid Bioservices (CDMO) PT Raised to $12 at RBC Capital
Jul 3, 2024 08:22AM KeyBanc Reiterates Overweight Rating on Avid Bioservices (CDMO)
Jul 3, 2024 06:20AM RBC Capital Reiterates Outperform Rating on Avid Bioservices (CDMO)